Cargando…

Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor‐induced interstitial lung disease in patients with non‐small cell lung cancer

BACKGROUND: Interstitial lung abnormalities (ILAs) are known to be a risk of drug‐induced pneumonitis. However, there are few reports on the relationship between ILAs and immune checkpoint inhibitor‐related interstitial lung disease (ICI‐ILD). We retrospectively investigated the clinical significanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murata, Daiki, Azuma, Koichi, Matama, Goushi, Zaizen, Yoshiaki, Matsuo, Norikazu, Murotani, Kenta, Tokito, Takaaki, Hoshino, Tomoaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807441/ https://www.ncbi.nlm.nih.gov/pubmed/36377039 http://dx.doi.org/10.1111/1759-7714.14718

Ejemplares similares

Survival and biomarkers for cachexia in non‐small cell lung cancer receiving immune checkpoint inhibitors
por: Murata, Daiki, et al.
Publicado: (2023)

Prognostic effect of cachexia in patients with non‐small cell lung cancer receiving immune checkpoint inhibitors
por: Matsuo, Norikazu, et al.
Publicado: (2023)

Granulomatous Lymphocytic Interstitial Lung Disease in Multiple Myeloma
por: Sasaki, Jun, et al.
Publicado: (2022)

Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease
por: Matama, Goushi, et al.
Publicado: (2023)

A case of cytokine release syndrome accompanied with COVID‐19 infection during treatment with immune checkpoint inhibitors for non‐small cell lung cancer
por: Murata, Daiki, et al.
Publicado: (2022)

Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial Pneumonias
por: Koga, Takuma, et al.
Publicado: (2022)

Lung Cancer with a Small Cell Carcinoma Component Diagnosed from Pleural Effusion and a Squamous Cell Carcinoma Component Diagnosed from the Tumor
por: Zaizen, Yoshiaki, et al.
Publicado: (2018)

A Rare Case of Diffuse Bilateral Minute Pulmonary Meningothelial-like Nodules Increasing over the Short Term and Resembling Metastatic Lung Cancer
por: Murata, Daiki, et al.
Publicado: (2022)

Clinical significance of high monocyte counts for the continuous treatment with nintedanib
por: Tsuneyoshi, Shingo, et al.
Publicado: (2023)

Correction to: clinical significance of high monocyte counts for the continuous treatment with nintedanib
por: Tsuneyoshi, Shingo, et al.
Publicado: (2023)

Accuracy of transbronchial biopsy as a rebiopsy method for patients with relapse of advanced non-small-cell lung cancer after systemic chemotherapy
por: Ishii, Hidenobu, et al.
Publicado: (2017)

The Characteristic of Transbronchial Lung Cryobiopsy in the Pathological Diagnosis of Hypersensitivity Pneumonitis
por: Ohno, Shuuhei, et al.
Publicado: (2023)

Successful Treatment of a Patient with Drug-Refractory Rheumatoid Arthritis-Associated Interstitial Lung Disease with Upadacitinib: A Case Report
por: Nishii, Yuuya, et al.
Publicado: (2023)

Sensitivity of transbronchial lung cryobiopsy in the diagnosis of different interstitial lung diseases
por: Zaizen, Yoshiaki, et al.
Publicado: (2022)

Clinical significance of plasma-free amino acids and tryptophan metabolites in patients with non-small cell lung cancer receiving PD-1 inhibitor: a pilot cohort study for developing a prognostic multivariate model
por: Azuma, Koichi, et al.
Publicado: (2022)

Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy
por: Sekine, Akimasa, et al.
Publicado: (2022)

Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor–Induced Interstitial Lung Disease Among Patients With Nonlung Cancers
por: Shimoji, Kiyofumi, et al.
Publicado: (2020)

Programmed cell death-ligand 1 expression and immunoscore in stage II and III non-small cell lung cancer patients receiving adjuvant chemotherapy
por: Ishii, Hidenobu, et al.
Publicado: (2017)

Concordance between sequential transbronchial lung cryobiopsy and surgical lung biopsy in patients with diffuse interstitial lung disease
por: Zaizen, Yoshiaki, et al.
Publicado: (2019)

Predictive value of CD73 expression for the efficacy of immune checkpoint inhibitors in NSCLC
por: Ishii, Hidenobu, et al.
Publicado: (2020)

Early Intervention of Pulmonary Rehabilitation for Fibrotic Interstitial Lung Disease Is a Favorable Factor for Short-Term Improvement in Health-Related Quality of Life
por: Matsuo, Satoshi, et al.
Publicado: (2021)

Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP)
por: Hino, Takuya, et al.
Publicado: (2021)

Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases
por: Wijsenbeek, Marlies S., et al.
Publicado: (2022)

Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
por: Zhou, Qian, et al.
Publicado: (2023)

Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
por: Matsuo, Norikazu, et al.
Publicado: (2016)

Interstitial lung abnormalities and physical function
por: Axelsson, Gisli Thor, et al.
Publicado: (2018)

Interstitial Lung Abnormalities: An Evolving Entity
por: Tomassetti, Sara, et al.
Publicado: (2022)

Enhanced immune complex formation in the lungs of patients with dermatomyositis
por: Zaizen, Yoshiaki, et al.
Publicado: (2023)

Interstitial lung abnormalities: Real‐world evidence
por: Rôlo Silvestre, Carina, et al.
Publicado: (2023)

Interstitial lung abnormalities: do symptoms matter?
por: Patel, Avignat S.
Publicado: (2023)

Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new
por: Leone, Paolo Maria, et al.
Publicado: (2020)

Interstitial lung abnormalities and interstitial lung diseases associated with cigarette smoking in a rural cohort undergoing surgical resection
por: Sangani, Rahul G., et al.
Publicado: (2022)

Potential Metabolic Biomarkers to Identify Interstitial Lung Abnormalities
por: Tan, Yong, et al.
Publicado: (2016)

Subclinical Interstitial Lung Abnormalities: Lumping and Splitting Revisited
por: Walsh, Simon L. F., et al.
Publicado: (2019)

Increased respiratory morbidity in individuals with interstitial lung abnormalities
por: Hoyer, Nils, et al.
Publicado: (2020)

Interstitial Lung Abnormalities: What Radiologists Should Know
por: Chae, Kum Ju, et al.
Publicado: (2021)

Interstitial lung abnormalities – current knowledge and future directions
por: Axelsson, Gisli Thor, et al.
Publicado: (2021)

Interstitial Lung Abnormalities and Aging Biomarkers: A Mediation
por: Oldham, Justin M.
Publicado: (2021)

Post COVID Interstitial Lung Abnormalities—Incidence and Management
por: Robertshaw, Mark, et al.
Publicado: (2023)

Bronchial epithelial gene expression and interstitial lung abnormalities
por: Menon, Aravind A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b641ibejfh47moh6c23f2k9mjk